Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Shin Poong Pharmaceuticals)"
Count: 32
Selected: 0
| NCT ID | Title |
|---|
| NCT04532931 | COVID-19 Treatment in South Africa | ||
| NCT03814616 | Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections | ||
| NCT03201770 | Cohort Event Monitoring Study of Pyramax® | ||
| NCT05633420 | Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients | ||
| NCT05574166 | A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356 | ||
| NCT05084911 | The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3) | ||
| NCT05058027 | Anti-adhesive Effect and Safety of MEDICURTAIN Applied to Undergoing Thyroid Surgery (Pivotal Study) | ||
| NCT05049434 | Efficacy and Safety for Medicurtain® in Prevention of Adhesion After Endoscopic Sinus Surgery (Pivotal Study) | ||
| NCT04770194 | Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008 | ||
| NCT04701606 | The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients | ||
| NCT04688281 | Spine Surgery for Adhesions in Patients Evaluated for Efficacy and Safety of MedicurtainⓇ (Pivotal Study) | ||
| NCT04672421 | The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) | ||
| NCT04638855 | The Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy (Pivotal Study) | ||
| NCT04479449 | Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA | ||
| NCT04475107 | The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients | ||
| NCT03288038 | The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia | ||
| NCT02944734 | Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension | ||
| NCT02787278 | Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA | ||
| NCT01926652 | Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg | ||
| NCT01757795 | Safety, Tolerability and Pharmacokinetics of SP-8203 | ||
| NCT04368910 | Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria | ||
| NCT01523002 | Drug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy Volunteers | ||
| NCT01383109 | Human Mass Balance Study of Pyronaridine | ||
| NCT01156389 | Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Study | ||
| NCT00682630 | Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet | ||
| NCT00541385 | Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients | ||
| NCT00440999 | Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria | ||
| NCT00422084 | Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients | ||
| NCT00403260 | Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients | ||
| NCT01868438 | Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations, in Healthy Volunteers | ||
| NCT01594931 | Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria | ||
| NCT00331136 | Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria |
